Kelly C Young-Wolff1, Sebastien C Fromont2, Kevin Delucchi2, Stephen E Hall2, Sharon M Hall2, Judith J Prochaska3. 1. Stanford Prevention Research Center, Department of Medicine, Stanford University, United States. 2. Department of Psychiatry, University of California, San Francisco, United States. 3. Stanford Prevention Research Center, Department of Medicine, Stanford University, United States. Electronic address: JPro@Stanford.edu.
Abstract
INTRODUCTION: Posttraumatic stress disorder (PTSD) is a risk factor for tobacco addiction. The majority of research on PTSD and smoking has been conducted with men, particularly combat veterans, and little is known about the association among women. In a clinical sample of women civilian smokers with serious mental illness (SMI), we examined the prevalence of PTSD symptomatology and associations with physical and mental health functioning, co-occurring substance use, nicotine dependence, and readiness to quit smoking. METHODS: 376 adult women smokers aged 18-73 were recruited from 7 acute inpatient psychiatry units and screened by diagnostic interview for current PTSD symptomatology (PTSD(+)). In multiple regressions, we examined the associations of screening PTSD(+) with physical and mental health functioning; past-month drug use; past-year substance use disorders; nicotine dependence and readiness to quit smoking. RESULTS: Nearly half the sample (43%) screened PTSD(+), which was significantly associated with the use of stimulants (OR=1.26) and opiates (OR=1.98), drug use disorders (OR=2.01), and poorer mental health (B=-2.78) but not physical health functioning. PTSD(+) status was unrelated to nicotine dependence, but predicted greater desire to quit smoking (B=2.13) and intention to stop smoking in the next month (OR=2.21). In multivariate models that adjusted for substance use disorders, physical and mental health functioning, and nicotine dependence, screening PTSD(+) remained predictive of greater desire and intention to quit smoking. CONCLUSION: PTSD symptomatology was common in our sample of women smokers with SMI and associated with not only worse substance use and mental health, but also greater readiness to quit smoking, suggesting the need for and potential interest in integrative PTSD-addiction treatment among women.
INTRODUCTION:Posttraumatic stress disorder (PTSD) is a risk factor for tobacco addiction. The majority of research on PTSD and smoking has been conducted with men, particularly combat veterans, and little is known about the association among women. In a clinical sample of women civilian smokers with serious mental illness (SMI), we examined the prevalence of PTSD symptomatology and associations with physical and mental health functioning, co-occurring substance use, nicotine dependence, and readiness to quit smoking. METHODS: 376 adult women smokers aged 18-73 were recruited from 7 acute inpatient psychiatry units and screened by diagnostic interview for current PTSD symptomatology (PTSD(+)). In multiple regressions, we examined the associations of screening PTSD(+) with physical and mental health functioning; past-month drug use; past-year substance use disorders; nicotine dependence and readiness to quit smoking. RESULTS: Nearly half the sample (43%) screened PTSD(+), which was significantly associated with the use of stimulants (OR=1.26) and opiates (OR=1.98), drug use disorders (OR=2.01), and poorer mental health (B=-2.78) but not physical health functioning. PTSD(+) status was unrelated to nicotine dependence, but predicted greater desire to quit smoking (B=2.13) and intention to stop smoking in the next month (OR=2.21). In multivariate models that adjusted for substance use disorders, physical and mental health functioning, and nicotine dependence, screening PTSD(+) remained predictive of greater desire and intention to quit smoking. CONCLUSION:PTSD symptomatology was common in our sample of women smokers with SMI and associated with not only worse substance use and mental health, but also greater readiness to quit smoking, suggesting the need for and potential interest in integrative PTSD-addiction treatment among women.
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori Journal: JAMA Date: 2010-12-08 Impact factor: 56.272
Authors: Sandra Baker Morissette; Matthew T Tull; Suzy Bird Gulliver; Barbara Wolfsdorf Kamholz; Rose T Zimering Journal: Psychol Bull Date: 2007-03 Impact factor: 17.737
Authors: Judith J Prochaska; Sebastien C Fromont; Kevin Delucchi; Kelly C Young-Wolff; Neal L Benowitz; Stephen Hall; Thomas Bonas; Sharon M Hall Journal: Health Psychol Date: 2014-01-27 Impact factor: 4.267
Authors: Weili Lu; Philip T Yanos; Jennifer D Gottlieb; Stephanie Marcello Duva; Steven M Silverstein; Haiyi Xie; Stanley D Rosenberg; Kim T Mueser Journal: Psychiatr Serv Date: 2012-08 Impact factor: 3.084
Authors: Karestan C Koenen; Michael J Lyons; Jack Goldberg; John Simpson; Wesley M Williams; Rosemary Toomey; Seth A Eisen; William True; Ming T Tsuang Journal: J Trauma Stress Date: 2003-10
Authors: Diann E Gaalema; Jennifer W Tidey; Danielle R Davis; Stacey C Sigmon; Sarah H Heil; Maxine L Stitzer; Michael J Desarno; Valeria Diaz; John R Hughes; Stephen T Higgins Journal: Nicotine Tob Res Date: 2019-12-23 Impact factor: 4.244